These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Butyrate inhibits mouse fibroblasts at a control point in the G1 phase. Wintersberger E, Mudrak I, Wintersberger U. J Cell Biochem; 1983; 21(3):239-47. PubMed ID: 6195168 [Abstract] [Full Text] [Related]
9. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells. Kim J, Park H, Im JY, Choi WS, Kim HS. Anticancer Res; 2007 Jan; 27(5A):3285-92. PubMed ID: 17970072 [Abstract] [Full Text] [Related]
13. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells. Huang YQ, Wang LW, Yan SN, Gong ZJ. Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742 [Abstract] [Full Text] [Related]
14. Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor. Nakamura M, Saito H, Ebinuma H, Wakabayashi K, Saito Y, Takagi T, Nakamoto N, Ishii H. J Cell Physiol; 2001 Jun; 187(3):392-401. PubMed ID: 11319763 [Abstract] [Full Text] [Related]
17. Specific cell cycle synchronization with butyrate and cell cycle analysis. Li C. Methods Mol Biol; 2011 Jun; 761():125-36. PubMed ID: 21755445 [Abstract] [Full Text] [Related]
18. HiNF-D (CDP-cut/CDC2/cyclin A/pRB-complex) influences the timing of IRF-2-dependent cell cycle activation of human histone H4 gene transcription at the G1/S phase transition. Aziz F, van Wijnen AJ, Stein JL, Stein GS. J Cell Physiol; 1998 Dec; 177(3):453-64. PubMed ID: 9808153 [Abstract] [Full Text] [Related]